FOX News: Business
FOXBusiness.com - Breaking news and video. Latest Current News: News, Investing, Technology, Personal Finance, Business Leaders, Travel, On Air, Small Business.
Updated: 39 min 5 sec ago
An M Science report and Jefferies survey suggest that longtime subscribers are balking at paying higher rates, but there's a bigger story at play here.
Low fees, good performance, and high yields make these the best dividend mutual funds for 2016.
Long guns saw a dramatic increase in sales this quarter, but this issue could stop such growth cold.
It's about to get way too easy to pay for things on the internet.
Strong pre-orders for the iPhone 7 drove up shares, but investors may be getting ahead of themselves.
Falling or flat energy and food prices could wipe out any chance of a decent raise for seniors in 2017.
There will be a lot of wining, dining, and some un-Disney-like debauchery going on at Disney World these next few weeks.
He was arguably the richest person who ever lived -- here's what you can learn straight from mouth of the original "Rockafella."
Some beaten-down biotechs might be worth the risk, while others are better left alone.
The rhetoric from the presidential candidate and the oil cartel drove double-digit rallies in Cloud Peak Energy, Cobalt International Energy, Hallador Energy, Tesco, Bellatrix Exploration last week.
A butterfly option spread is a neutral strategy with limited downside risk.
The airlines industry is heavily committed to reducing emissions, but success in renewable fuels has historically been elusive.
Note: This article is courtesy of Iris.xyz By Frank Holmes As we all know, exchange-traded funds (ETFs) have increasingly become the hot menu item, attracting a lot of money away from actively-managed funds such as mutual funds. But don’t discount active management just yet! There’s still plenty of room in your portfolio for this type […]
With rooftop solar energy becoming a viable option for customers and energy storage on its way, utilities have a lot to worry about.
Second quarter financial results failed to impress investors, but there are good reasons to consider owning this company.
Note: This article is courtesy of Iris.xyz By Douglas Heikkinen Dorsey Wright: Your Turnkey Portfolio Construction Solution IRIS interviews Tom Dorsey, founder, Dorsey, Wright & Associates (DWA), to discuss the development of their fintech platform. Dorsey, Wright & Associates (DWA), a Nasdaq Company, has been at the forefront of technical analysis and relative strength investing […]
Note: This article is courtesy of Iris.xyz By Carolyn Rose Kick If you’re not already working with Millennials, born 1980-2000, you should plan on working with them in the near future. Millennials are set to inherit over 30+ trillion in wealth from the Baby Boomers in coming years. Now is the time to develop a […]
Both of these clinical-stage biotechs are big losers in 2016 so far. Which has the better chance of becoming a winner?
Want higher benefits for you and your spouse? Here's what you need to do.
Janet Woodcock's advocacy as director of the FDA's Center for Drug Evaluation and Research proved vital to the company's winning accelerated approval of its Duchenne muscular dystrophy drug.